FFCP PHASE1:Mm9::chr18:82124383..82124401,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=50|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr18:82124383..82124401,-|id=chr18:82124383..82124401,-|ontology_enrichment_celltype=CL:0000084!4.98e-17!11;CL:0000827!4.98e-17!11;CL:0000838!1.29e-15!12;CL:0000542!2.02e-14!13;CL:0000051!2.02e-14!13;CL:0000738!4.92e-11!17;CL:0002087!4.92e-11!17;CL:0002031!1.66e-10!25;CL:0000625!6.23e-09!1;CL:0000988!3.77e-08!32;CL:0002032!3.77e-08!32;CL:0000037!3.77e-08!32;CL:0000566!3.77e-08!32;CL:0000837!3.77e-08!32;CL:0000791!6.38e-08!9;CL:0000789!6.38e-08!9;CL:0002420!6.38e-08!9;CL:0002419!6.38e-08!9;CL:0000790!6.38e-08!9|ontology_enrichment_celltype_v019_2=CL:0000625,1.10e-29,1;CL:0000084,1.34e-24,11;CL:0000827,1.34e-24,11;CL:0000838,1.18e-22,12;CL:0000542,5.26e-21,13;CL:0000051,5.26e-21,13;CL:0000738,2.41e-16,17;CL:0002087,2.41e-16,17;CL:0002031,1.80e-11,25;CL:0000988,3.42e-09,32;CL:0002032,3.42e-09,32;CL:0000037,3.42e-09,32;CL:0000837,3.42e-09,32|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000029!7.41e-09!1;UBERON:0001097!7.41e-09!1;UBERON:0003968!7.41e-09!1;UBERON:0008785!7.41e-09!1;UBERON:0001467!7.41e-09!1;UBERON:0001421!7.41e-09!1;UBERON:0002193!5.14e-07!48|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0.171200729931206,0.0874204024189974,0,0,0,0.157731082679119,0,0,0,32.9645957986939,43.6203647862022,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.34437519656986,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.142371680799103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.258937883647172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228778173206523,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.129920822977795,0,0,0,0,0,0,0,0,0.192423683280659,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0574354689556133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr18:82124383..82124401,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=50 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr18:82124383..82124401,- | |||
|description=CAGE_peak_at_chr18:82124383..82124401,- | |||
|id=chr18:82124383..82124401,- | |||
|ontology_enrichment_celltype=CL:0000084!4.98e-17!11;CL:0000827!4.98e-17!11;CL:0000838!1.29e-15!12;CL:0000542!2.02e-14!13;CL:0000051!2.02e-14!13;CL:0000738!4.92e-11!17;CL:0002087!4.92e-11!17;CL:0002031!1.66e-10!25;CL:0000625!6.23e-09!1;CL:0000988!3.77e-08!32;CL:0002032!3.77e-08!32;CL:0000037!3.77e-08!32;CL:0000566!3.77e-08!32;CL:0000837!3.77e-08!32;CL:0000791!6.38e-08!9;CL:0000789!6.38e-08!9;CL:0002420!6.38e-08!9;CL:0002419!6.38e-08!9;CL:0000790!6.38e-08!9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000625,1.10e-29,1;CL:0000084,1.34e-24,11;CL:0000827,1.34e-24,11;CL:0000838,1.18e-22,12;CL:0000542,5.26e-21,13;CL:0000051,5.26e-21,13;CL:0000738,2.41e-16,17;CL:0002087,2.41e-16,17;CL:0002031,1.80e-11,25;CL:0000988,3.42e-09,32;CL:0002032,3.42e-09,32;CL:0000037,3.42e-09,32;CL:0000837,3.42e-09,32 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000029!7.41e-09!1;UBERON:0001097!7.41e-09!1;UBERON:0003968!7.41e-09!1;UBERON:0008785!7.41e-09!1;UBERON:0001467!7.41e-09!1;UBERON:0001421!7.41e-09!1;UBERON:0002193!5.14e-07!48 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0.171200729931206,0.0874204024189974,0,0,0,0.157731082679119,0,0,0,32.9645957986939,43.6203647862022,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.34437519656986,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.142371680799103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.258937883647172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228778173206523,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.129920822977795,0,0,0,0,0,0,0,0,0.192423683280659,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0574354689556133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr18:82124383..82124401,- | |||
}} |
Latest revision as of 04:40, 6 August 2015
Short description: | p@chr18:82124383..82124401, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr18:82124383..82124401, - |
Coexpression cluster: | MCL_coexpression_mm9:50 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
CD8-positive, alpha-beta T cell | 1.10e-29 | 1 |
T cell | 1.34e-24 | 11 |
pro-T cell | 1.34e-24 | 11 |
lymphoid lineage restricted progenitor cell | 1.18e-22 | 12 |
lymphocyte | 5.26e-21 | 13 |
common lymphoid progenitor | 5.26e-21 | 13 |
leukocyte | 2.41e-16 | 17 |
nongranular leukocyte | 2.41e-16 | 17 |
hematopoietic lineage restricted progenitor cell | 1.80e-11 | 25 |
hematopoietic cell | 3.42e-09 | 32 |
hematopoietic oligopotent progenitor cell | 3.42e-09 | 32 |
hematopoietic stem cell | 3.42e-09 | 32 |
hematopoietic multipotent progenitor cell | 3.42e-09 | 32 |